SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 155 filers reported holding SAGE THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is 1.15 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $208,000 | -97.0% | 2,875 | -94.2% | 0.00% | -96.8% |
Q3 2019 | $6,996,000 | -38.1% | 49,865 | -19.2% | 0.10% | -34.9% |
Q2 2019 | $11,305,000 | +13.7% | 61,745 | -1.2% | 0.15% | +9.8% |
Q1 2019 | $9,945,000 | +26.8% | 62,525 | -23.6% | 0.13% | +12.7% |
Q4 2018 | $7,844,000 | -35.8% | 81,885 | -5.3% | 0.12% | -23.4% |
Q3 2018 | $12,211,000 | -19.8% | 86,450 | -11.1% | 0.15% | -20.2% |
Q2 2018 | $15,230,000 | +67.8% | 97,295 | +72.6% | 0.19% | +66.4% |
Q1 2018 | $9,077,000 | +47.7% | 56,355 | +51.1% | 0.12% | +65.7% |
Q4 2017 | $6,144,000 | +67.5% | 37,300 | -36.7% | 0.07% | +66.7% |
Q3 2017 | $3,669,000 | -35.5% | 58,900 | -17.6% | 0.04% | -38.2% |
Q2 2017 | $5,690,000 | +31.1% | 71,450 | +17.0% | 0.07% | +28.3% |
Q1 2017 | $4,339,000 | +34.8% | 61,050 | -3.2% | 0.05% | +29.3% |
Q4 2016 | $3,219,000 | +57.6% | 63,050 | +42.1% | 0.04% | +64.0% |
Q3 2016 | $2,043,000 | -14.2% | 44,375 | -43.9% | 0.02% | +66.7% |
Q2 2016 | $2,382,000 | +88.0% | 79,050 | +100.0% | 0.02% | -11.8% |
Q1 2016 | $1,267,000 | -44.1% | 39,525 | +1.7% | 0.02% | -45.2% |
Q4 2015 | $2,266,000 | +61.7% | 38,875 | +17.4% | 0.03% | +63.2% |
Q3 2015 | $1,401,000 | -15.4% | 33,100 | +45.8% | 0.02% | -5.0% |
Q2 2015 | $1,657,000 | +101.3% | 22,700 | +38.6% | 0.02% | +100.0% |
Q1 2015 | $823,000 | – | 16,375 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Integral Health Asset Management, LLC | 311,000 | $10,294,000 | 2.68% |
Palo Alto Investors LP | 851,719 | $28,192,000 | 2.18% |
Boxer Capital, LLC | 1,094,000 | $36,211,000 | 1.86% |
DAFNA Capital Management LLC | 180,306 | $5,968,000 | 1.56% |
Deep Track Capital, LP | 675,000 | $22,343,000 | 1.43% |
Bellevue Group AG | 3,052,404 | $101,034,000 | 1.17% |
Ikarian Capital, LLC | 250,000 | $8,275,000 | 1.09% |
Ikarian Capital, LLC | 249,907 | $8,272,000 | 1.09% |
Artal Group S.A. | 750,000 | $24,825,000 | 1.04% |
SECTOR GAMMA AS | 118,476 | $3,922,000 | 0.85% |